Variations in the Apolipoprotein E APOE gene, particularly the APOE4 allele, are a well-studied risk of developing AD because they are involved in decreased β-amyloid clearance, elevated microglial proinflammatory activation, disturbed glucose and lipid metabolism, and synaptic disorganization [17]. This evidence concerns the gene APOE and Alzheimer disease.